Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells

BACKGROUND: Nitrogen-containing bisphosphonates (N-BPs) have been designed to inhibit osteoclast-mediated bone resorption. However, it is now accepted that part of their anti-tumor activities is related to interference with the mevalonate pathway. METHODS: We investigated the effects of zoledronic a...

Descripción completa

Detalles Bibliográficos
Autores principales: Goffinet, M, Thoulouzan, M, Pradines, A, Lajoie-Mazenc, I, Weinbaum, Carolyn, Faye, JC, Séronie-Vivien, S
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1434759/
https://www.ncbi.nlm.nih.gov/pubmed/16539721
http://dx.doi.org/10.1186/1471-2407-6-60

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1434759/
https://www.ncbi.nlm.nih.gov/pubmed/16539721
http://dx.doi.org/10.1186/1471-2407-6-60

Ejemplares similares